Stocks Health care IRMD
NASDAQ · Health careIradimed Corp (IRMD)
Iradimed Corp brought in $86.3M of revenue over the twelve months to June 30, 2026, up 11.2% from a year earlier. Net income was $23.1M, a net margin of 26.7%. Operating cash flow minus capital spending left $17.2M of free cash flow in fiscal 2025. At June 30, 2026 it held $59.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 31, 2026.
What Iradimed Corp does
Iradimed Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker IRMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $83.8M | $22.5M | $1.75 | $17.2M |
| 2024 | $73.2M | $19.2M | $1.50 | $17.6M |
| 2023 | $65.6M | $17.2M | $1.35 | $6M |
| 2022 | $53.3M | $12.8M | $1.02 | $9.2M |
| 2021 | $41.8M | $9.3M | $0.74 | $10.8M |
| 2020 | $31.7M | $1.4M | $0.11 | $5.4M |
Latest SEC filings
What Iradimed Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 18, 2026Quarterly results 8-K/A
- July 31, 2026Quarterly report 10-Q · period to June 30, 2026
- July 31, 2026Other event 8-K
- July 28, 2026Passive stake (5% or more) SCHEDULE 13G
- June 24, 2026
- May 14, 2026Passive stake changed SCHEDULE 13G/A
- May 1, 2026Quarterly report 10-Q · period to March 31, 2026
- May 1, 2026
- April 30, 2026
- April 30, 2026Proxy statement DEF 14A
Questions about IRMD
What does Iradimed Corp do?
Iradimed Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker IRMD.
Is Iradimed Corp profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $23.1M on revenue of $86.3M, a net margin of 26.7%.
How much revenue does Iradimed Corp make?
Over the twelve months to June 30, 2026 Iradimed Corp reported revenue of $86.3M. That is 11.2% more than a year earlier.
When did Iradimed Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 31, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 25, 2026.
Similar companies
Follow IRMD
Get an email when Iradimed Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow IRMD: get an email when it filesWhere the numbers come from
Financial figures are the values Iradimed Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.